Regeneron Pharmaceuticals
REGN
#117
Rank
S$165.77 B
Marketcap
$1,504
Share price
0.11%
Change (1 day)
33.95%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $50.35

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $48.66. In 2022 the company made an earnings per share (EPS) of $52.78 a decrease over its 2021 EPS that were of $99.58.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$50.35-4.6%
2022$52.78-47%
2021$99.58133.36%
2020$42.6769.13%
2019$25.23-14.44%
2018$29.49100.71%
2017$14.6931.78%
2016$11.1538.96%
2015$8.0272.55%
2014$4.65-17.55%
2013$5.64-44.98%
2012$10.25-422.54%
2011-$3.1892.13%
2010-$1.6549.41%
2009-$1.11-15.84%
2008-$1.32-36.88%
2007-$2.08-9.6%
2006-$2.314.12%
2005-$2.21-323.68%
2004$0.99-135.51%
2003-$2.79-24.38%
2002-$3.6956.35%
2001-$2.36187.3%
2000-$0.82-16%
1999-$0.98177.78%
1998-$0.35-35.71%
1997-$0.55-68.42%
1996-$1.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$18.43-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.35-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.04-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.35-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.87-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.14-91.49%๐Ÿ‡ซ๐Ÿ‡ท France